It is our privilege to count among our partners: pharmaceutical companies; public and private institutions; healthcare professionals; the scientific community; and service providers. Our experienced business development team is constantly looking out for new opportunities and partnerships.
From an internal point of view, HRA Pharma brings to the table experience in clinical insight, product development, regulatory matters, marketing, market access, and supply chain capabilities. We are adept at launching new brands on a global scale and at understanding the needs of both healthcare professionals and patients.
Our products are marketed in more than 70 countries.
We are able to leverage our size and set up to adapt to the needs of our partners and we are nimble and adept at doing so. Our wealth of experience and flexibility when structuring deals, for example, has enabled us to maximize the value of our portfolio via in- and out- licensing agreements. We currently market both proprietary and in–licensed products in France and parts of Europe, and out-license our products to marketing partners in other areas of the world.
We are able to set-up joint clinical trials, co-marketing and co-promotion.
In less than 18 years, we have signed: 2.169 agreements, including 154 product transactions and 175 research collaborations.
HRA Pharma is always open to pursuing new opportunities in order to broaden our therapeutic reach and meet the needs of patients across the world.